L. Andres Sirulnik

L. Andres Sirulnik, MD, PhD joined Regeneron in 2020 and serves as Senior Vice President, Translational & Clinical Sciences, Hematology, leading strategic program direction and clinical sciences work for our early- and late-stage oncologic hematology and late-stage non-oncology hematology portfolios. Before joining Regeneron, Dr. Sirulnik was Chief Medical Officer at Merus N.V., a clinical-stage immuno-oncology company. Prior to Merus N.V., he spent a decade at Novartis in various roles of increasing responsibility, ultimately overseeing the clinical strategy for their immuno-oncology portfolio. Dr. Sirulnik is a licensed physician, formerly practicing at Dana-Farber Cancer Institute and Brigham and Women’s Hospital and was a fellow in hematology/oncology at Mount Sinai Health System. He completed his medical residency at North Shore Long Island Jewish (LIJ) Health System and conducted post doctorate work at Columbia University. He received his PhD in Medicine and Molecular Biology from King’s College, University of Cambridge and his MD from the University of Buenos Aires.